Clinical Trial Update: Evaluation of Tranexamic Acid in Myelodysplastic Syndromes and Acute Myeloid Leukemia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating tranexamic acid in patients with myelodysplastic syndromes and acute myeloid leukemia and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Drugs mentioned

• TRANEXAMIC ACID (TRANEXAMIC ACID)

Snippet

Sponsor: University of Manitoba | Conditions: Myelodysplastic Syndromes, Acute Myeloid Leukemia | Phase 2 | Status: RECRUITING